Product category:
Cell/tissue handling and counting
News Release from: Guava Technologies | Subject: PCA
Edited by the Laboratorytalk Editorial
Team on 01 April 2003
World's first personal cell analysis
system
Using samples only a few microlitres in volume, experiments can be started sooner and finished faster, streamlining the entire research and development process
Available from Guava Technologies, the PCA is claimed to be the world's first personal cell analysis system, enabling scientists engaged in cell-based discovery to easily perform advanced assays with fewer cells than required by other methods Using samples only a few microlitres in volume, experiments can be started sooner and finished faster, streamlining the entire R and D process
This article was originally published on Laboratorytalk on 12 Apr 2007 at 8.00am (UK)
Related stories
Stem cell viability testing is robust and reliable
Using the Guava PCA system, Cells4Life is able to ensure that only samples containing a high percentage of viable (living) cells are cryopreserved for storage
FDA 510(k) clearance of EZCD4 for CD4 Monitoring
Guava Technologies has received 510(k) clearance from the US FDA for the EZCD4, which includes the EZCD4 Assay, the PCA Instrument and CytoSoft v2.3 software, incorporating three modules
As so little sample is required for each assay, the Guava PCA saves precious cells while still giving highly precise and accurate results.The Guava PCA system improves cell counting and viability measurements, as well as screening assays used by researchers everywhere for characterising cells.
Its ultra-compact size and ease of use makes the Guava PCA system indispensable to all scientists who need immediate access to fast and simple cell culture monitoring and screening assays.
Current cell monitoring and screening assays include the ViaCount assay for cell counting, apoptosis, and viability assessent, all in one test; the Express assay for a variety of applications, including protein expression, hybridoma screening, CD marker identification, bead based supernatant protein/antigen quantification, compound profiling, intracellular protein expression and GPCR expression, and three apoptosis assays for the detection of early, mid- and late apoptotic events.
From the quick installation and minimal training time required for operation, to the rapid assay results, the Guava PCA system is designed to save the operator time, every step of the way.
Designed to accelerate cell-based discovery, the Guava PCA offers turnkey operation in an integrated system consisting of the compact PCA instrument, software to automatically analyse and archive data, and optimised reagents.
To accommodate evolving assay needs, the Guava PCA system is expandable.
• Guava Technologies: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
